GNH USA

Europe — EMA

Lenalidomid Teva

GNH USA supplies Lenalidomid Teva (Lenalidomide), an antineoplastic for multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma. Request a quote.

Lenalidomide

Request sourcing

1
Pack/s

What is Lenalidomide?

Lenalidomide, the active ingredient in Lenalidomid Teva, is an immunomodulatory drug (IMiD) presented as an oral formulation for oral use. It treats multiple myeloma, myelodysplastic syndromes and mantle cell lymphoma in adult patients.

GNH USA supplies Lenalidomid Teva as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Lenalidomide used for?

Lenalidomid Teva is an immunomodulatory agent used in hematologic malignancies.

Multiple Myeloma: improves progression‑free survival and disease control in adult patients. Myelodysplastic Syndromes: reduces transfusion dependence and improves blood counts in patients with del(5q) cytogenetic abnormality. Mantle Cell Lymphoma: contributes to disease remission when used in combination therapy for adult patients.

What are the side effects of Lenalidomide?

Lenalidomid Teva may cause a range of adverse reactions.

Common Side Effects: - Fatigue - Neutropenia - Thrombocytopenia - Diarrhea - Rash - Anemia

Serious or Rare Side Effects: - Venous thromboembolism - Secondary primary malignancies - Severe neutropenia with infection risk - Hepatic toxicity - Tumor lysis syndrome - Interstitial lung disease

What precautions apply to Lenalidomide?

Use of Lenalidomid Teva requires careful monitoring and patient counseling.

Monitor blood counts: perform regular CBC to detect cytopenias. Assess for thrombotic risk: evaluate history of clotting disorders. Avoid use in pregnancy: drug is teratogenic; ensure effective contraception. Adjust dose in renal impairment: follow prescribing guidelines for reduced renal function. Store at ambient temperature: keep below 25°C in original container, protect from moisture.

What does Lenalidomide interact with?

Lenalidomid Teva can interact with other medicines, affecting safety or efficacy.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors: may increase lenalidomide exposure. - Anticoagulants: increased risk of bleeding. - Live vaccines: risk of infection due to immunosuppression.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers: may reduce therapeutic effect. - Other myelosuppressive agents: monitor blood counts closely. - HIV protease inhibitors: may alter drug metabolism.

Frequently asked questions

What conditions is Lenalidomid Teva used for?+
Lenalidomid Teva contains lenalidomide and is indicated for the treatment of multiple myeloma, myelodysplastic syndromes with del(5q) cytogenetic abnormality, and mantle cell lymphoma in adult patients, typically as part of a prescribed therapeutic regimen.
How does lenalidomide work in the body?+
Lenalidomide binds to the cereblon component of the CRL4‑CRBN E3 ubiquitin ligase, leading to selective degradation of transcription factors that regulate cell survival. This results in immune modulation, inhibition of new blood‑vessel formation, and promotion of programmed cell death in malignant cells.
What is the usual dose of Lenalidomid Teva?+
The specific dose of Lenalidomid Teva is determined by the prescribing clinician based on the patient’s diagnosis, disease stage, renal function, and other individual factors. Only a qualified healthcare professional should set the dosing schedule.
Is Lenalidomid Teva safe during pregnancy or breastfeeding?+
Lenalidomid Teva is classified as teratogenic and is contraindicated in pregnancy. Women of child‑bearing potential must use effective contraception. Safety during breastfeeding has not been established, and breastfeeding is generally not recommended while on therapy.
How do I order Lenalidomid Teva from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Lenalidomid Teva compare with other treatments for multiple myeloma?+
Lenalidomid Teva belongs to the immunomodulatory drug class, offering a distinct mechanism compared with proteasome inhibitors or monoclonal antibodies. It is often used in combination regimens and may provide benefits in disease control and progression‑free survival, though choice of therapy depends on individual patient factors and physician judgment.
What are the recommended storage conditions for Lenalidomid Teva?+
Lenalidomid Teva should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture and direct sunlight to maintain stability throughout its shelf life.
How is Lenalidomid Teva administered?+
Lenalidomid Teva is taken orally, usually as a tablet or capsule, with or without food as directed by the prescriber. Patients should follow the exact schedule and instructions provided by their healthcare professional.
What are the most serious risks associated with Lenalidomid Teva?+
Serious risks include venous thromboembolism, severe neutropenia leading to infection, secondary primary malignancies, hepatic toxicity, and rare pulmonary complications such as interstitial lung disease. Patients should be monitored closely for these events.
Who should not use Lenalidomid Teva?+
Lenalidomid Teva should not be used by individuals with known hypersensitivity to lenalidomide or any excipients, pregnant women, or patients with severe renal impairment unless dose adjustments are made. It is also contraindicated in patients with active uncontrolled infections.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Lenalidomide
Route
Oral Use
Manufacturer
Teva B.V
Origin
EU

Related products